
|Videos|February 17, 2023
Selecting Patients with R/R MM for Treatment With Bispecifics
Krina Patel, MD, MSc, explains which patients with relapsed/refractory multiple myeloma she would not treat with CAR T-cell therapy, and the options after disease progression on CAR-T.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Evaluating the Molecular Landscape in Endometrial Cancer to Optimize Treatment
2
Bria-IMT Shows Extended Survival in Advanced Metastatic Breast Cancer
3
Blinatumomab Plus Chemo Show Improved Survival in Infants with KMT2A-r ALL
4
Neoadjuvant Systemic Therapy Explored in Head and Neck Cancer Trial
5




















